top of page
MyotonicPipeline.com
Vertex Pharmaceuticals / CRISPR Therapeutics
Approach: Gene Editing
Status: Preclinical
Press Release announcing Vertex / CRISPR Therapeutics collaboration
4.27.20 Press Release announcing Vertex / Affinia deal for AAV delivery technology
2.15.22 Press Release announcing CRISPR earned $12.5 million milestone from Vertex related to advancement of myotonic dystrophy drug candidate.
bottom of page